Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility
Addiction
.
2012 Dec;107(12):2076-7.
doi: 10.1111/j.1360-0443.2012.03939.x.
Authors
Pascal Borry
1
,
Lidewij Henneman
Affiliation
1
Centre for Biomedical Ethics and Law, Katholieke Universiteit Leuven, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium.
[email protected]
PMID:
23167641
DOI:
10.1111/j.1360-0443.2012.03939.x
No abstract available
Publication types
Comment
MeSH terms
Genetic Predisposition to Disease / prevention & control*
Genetic Testing / methods*
Humans
Substance-Related Disorders / prevention & control*